Repligen Corporation (RGEN) Q4 FY25 Earnings Call

2026 guidance pairs 9%-13% organic growth with 150 basis points of operating-margin expansion.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-02-25
Length61 minutes
EPS$0.49
EPS consensus$0.44
Revenue$197.9M
Revenue consensus$192.2M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q1 FY26 · Q2 FY25

Read the full Q4 FY25 earnings call transcript

All RGEN earnings · Back to RGEN overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.